Zilfou Therapeutics, Inc., Allentown, Pennsylvania 18104, USA.
Cold Spring Harb Perspect Biol. 2009 Nov;1(5):a001883. doi: 10.1101/cshperspect.a001883.
The majority of human cancers acquire mutations that abrogate the p53 tumor suppressor network and, as a consequence, p53 is one of the most extensively studied proteins in cancer research. Because of its potent tumor suppressive activity, it is widely assumed that a molecular understanding of p53 action will produce fundamental insights into natural processes that limit tumorigenesis and may identify key molecular targets for therapeutic intervention. p53 functions largely as a transcription factor, and can trigger a variety of antiproliferative programs by activating or repressing key effector genes. Despite a significant body of literature detailing the biochemical and biological functions of p53, much remains to be elucidated. Indeed, the p53 network is as complex and enigmatic as it is relevant. It is the goal of this article, written 30 years after the discovery of p53, to present a concise review of the tumor suppressor role of the p53 network and to highlight the context-dependent nature of p53 target-gene functions.
大多数人类癌症都会获得使抑癌蛋白 p53 网络失活的突变,因此,p53 是癌症研究中研究最多的蛋白质之一。由于其强大的肿瘤抑制活性,人们普遍认为对 p53 作用的分子理解将产生对限制肿瘤发生的自然过程的基本认识,并可能确定治疗干预的关键分子靶标。p53 主要作为转录因子发挥作用,并且可以通过激活或抑制关键效应基因来触发各种抗增殖程序。尽管有大量文献详细描述了 p53 的生化和生物学功能,但仍有许多问题需要阐明。事实上,p53 网络与其相关性一样复杂和神秘。本文是在发现 p53 30 年后撰写的,旨在简要回顾 p53 网络的抑癌作用,并强调 p53 靶基因功能的上下文依赖性。